Citations (58)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (8)
Jonathan Corren, David J Jackson, Thomas B Casale, Larry Borish, Klaus F Rabe, William W Busse, Jorge F Maspero, Daniel J Jackson, Nadia Daizadeh, Arman Altincatal, Amr Radwan, Angela Khodzhayev, Michel Djandji, Juby A Jacob-Nara, Paul J Rowe & Yamo Deniz. (2023) Dupilumab Efficacy in Patients with Uncontrolled Moderate-to-Severe Type 2 Asthma Regardless of Perennial Aeroallergen Sensitization. Journal of Asthma and Allergy 16, pages 249-260.
Read now
Read now
Jorge F. Maspero, Guido Cardona, Patricia Schonffeldt, Alberto Tolcachier, Sandra N. González-Diaz, Anahi Yañez, Clovis E. Galvao, Jerome Msihid, Rebecca Gall, Shahid Siddiqui, Paul J. Rowe, Yamo Deniz, Juby A. Jacob-Nara & Michel Djandji. (2023) Dupilumab efficacy and safety in Latin American patients with uncontrolled, moderate-to-severe asthma: phase 3 LIBERTY ASTHMA QUEST study. Journal of Asthma 60:5, pages 981-990.
Read now
Read now
Agamemnon Bakakos, Nikoletta Rovina, Stelios Loukides & Petros Bakakos. (2022) Biologics in severe asthma: Outcomes in clinical trials-Similarities and differences. Expert Opinion on Biological Therapy 22:7, pages 855-870.
Read now
Read now
Maria De Filippo, Martina Votto, Amelia Licari, Fabio Pagella, Marco Benazzo, Giorgio Ciprandi & Gian Luigi Marseglia. (2021) Novel therapeutic approaches targeting endotypes of severe airway disease. Expert Review of Respiratory Medicine 15:10, pages 1303-1316.
Read now
Read now
Luane Marques Mello, Karynna P. Viana, Felipe Moraes dos Santos, Luciana T. M. Saturnino, Michelle L. Kormann, Evelyn Lazaridis, Cinthia D. Torreão, Claudia R. Soares, Gabriela A. Abreu, Valmar Bião de Lima, Gabriela P. Pinheiro, Aline Lima-Matos, Eduardo Vieira Ponte, Divya Mohan, John H. Riley & Alvaro A. Cruz. (2021) Severe asthma and eligibility for biologics in a Brazilian cohort. Journal of Asthma 58:7, pages 958-966.
Read now
Read now
Cristoforo Incorvaia, Francesco Pucciarini, Eleni Makri, Bruna L Gritti & Erminia Ridolo. (2020) Allergen immunotherapy for respiratory allergy: to what extent can the risk of systemic reactions be reduced?. Expert Opinion on Drug Safety 19:7, pages 843-848.
Read now
Read now
Alicia Padilla Galo, Marina Labor, Angelica Tiotiu, Ilaria Baiardini, Nicola Scichilone & Fulvio Braido. (2018) Impact of reslizumab on outcomes of severe asthmatic patients: current perspectives. Patient Related Outcome Measures 9, pages 267-273.
Read now
Read now
Ignacio Esteban-Gorgojo, Darío Antolín-Amérigo, Javier Domínguez-Ortega & Santiago Quirce. (2018) Non-eosinophilic asthma: current perspectives. Journal of Asthma and Allergy 11, pages 267-281.
Read now
Read now
Articles from other publishers (50)
Heung-Woo Park. (2023) Biological products in allergy practice: the beginning of a new era. Journal of the Korean Medical Association 66:9, pages 518-521.
Crossref
Crossref
Yinhe Feng, Xiaoyin LiuYubin Wang, Rao Du & Hui Mao. (2023) Delineating asthma according to inflammation phenotypes with a focus on paucigranulocytic asthma. Chinese Medical Journal 136:13, pages 1513-1522.
Crossref
Crossref
Xuexuan Ding, Jingtong Qin, Fangfang Huang, Fuhai Feng & Lianxiang Luo. (2023) The combination of machine learning and untargeted metabolomics identifies the lipid metabolism -related gene CH25H as a potential biomarker in asthma. Inflammation Research 72:5, pages 1099-1119.
Crossref
Crossref
Yang Liu, Li Fu & Zheng Liu. (2023) The Role and Clinical Relevance of Osteopontin in Allergic Airway Diseases. Journal of Clinical Medicine 12:6, pages 2433.
Crossref
Crossref
Ilka Jorde, Jens Schreiber & Sabine Stegemann-Koniszewski. (2022) The Role of Staphylococcus aureus and Its Toxins in the Pathogenesis of Allergic Asthma. International Journal of Molecular Sciences 24:1, pages 654.
Crossref
Crossref
Lesina V.S., Starodubtseva I.A., Chulkov V.C., Vasilyeva L.V., Ektova N.A. & Ektova L.A.. (2022) THE INFLUENCE OF FEATURES OF THE CLINICAL COURSE, THERAPEUTIC APPROACH ON THE RISK OF DEVELOPMENT AND PROGRESSION OF CARDIOVASCULAR PATHOLOGY IN PATIENTS WITH BRONCHIAL ASTHMA. "Medical & pharmaceutical journal "Pulse", pages 29-34.
Crossref
Crossref
Antolín López-Viña, Rocío M. Díaz Campos, Andrea Trisan Alonso & Carlos Melero Moreno. (2022) Uncontrolled severe T2 asthma: Which biological to choose? A biomarker-based approach. Frontiers in Allergy 3.
Crossref
Crossref
Aşkın Gülşen. 2022. Recent Advances in Asthma Research and Treatments. Recent Advances in Asthma Research and Treatments.
H. Vanneste, E. Derom, G. Brusselle & G. Joos. (2022) NO in de uitgeademde lucht, een overzicht. Tijdschrift voor Geneeskunde.
Crossref
Crossref
Seung Koo Yang, Seong-Ho Cho & Dae Woo Kim. (2022) Interpretation of Clinical Efficacy of Biologics in Chronic Rhinosinusitis With Nasal Polyps via Understanding the Local and Systemic Pathomechanisms. Allergy, Asthma & Immunology Research 14:5, pages 465.
Crossref
Crossref
Giorgio Walter Canonica, Francesco Blasi, Nunzio Crimi, Pierluigi Paggiaro, Alberto Papi, Francesca Fanelli, Annalisa Stassaldi & Gianluca Furneri. (2021) Defining type 2 asthma and patients eligible for dupilumab in Italy: a biomarker-based analysis. Clinical and Molecular Allergy 19:1.
Crossref
Crossref
Mariska P. M. van den Berg, Susan Nijboer-Brinksma, I. Sophie T. Bos, Maarten van den Berge, David Lamb, Martijn van Faassen, Ido P. Kema, Reinoud Gosens & Loes E. M. Kistemaker. (2021) The novel TRPA1 antagonist BI01305834 inhibits ovalbumin-induced bronchoconstriction in guinea pigs. Respiratory Research 22:1.
Crossref
Crossref
Glenn Van Hulst, Fabrice Bureau & Christophe J. Desmet. (2021) Eosinophils as Drivers of Severe Eosinophilic Asthma: Endotypes or Plasticity?. International Journal of Molecular Sciences 22:18, pages 10150.
Crossref
Crossref
Jason Ma, Ming-Xun Liu, Li-Chen Chen, Jiann-Jong Shen & Ming-Ling Kuo. (2021) Ding Chuan Tang Attenuates Airway Inflammation and Eosinophil Infiltration in Ovalbumin-Sensitized Asthmatic Mice. BioMed Research International 2021, pages 1-10.
Crossref
Crossref
Yusuke Suzuki, Tomoya Hayashi, Ryoma Yokoyama, Fumika Nakagawa, Joe Inoue, Taishi Higashi, Risako Onodera & Keiichi Motoyama. (2021) Fasting impairs type 2 helper T cell infiltration in the lung of an eosinophilic asthma mouse model. FEBS Open Bio 11:9, pages 2619-2630.
Crossref
Crossref
Jae-Woo Jung, Hae-Sim Park, Choon-Sik Park, Sang-Heon Cho, Inseon S. Choi, Hee-Bom Moon, Soon Seog Kwon, Ho Joo Yoon, Jung Won Park, Jong-Myung Lee, Dong-Chull Choi & Byoung Whui Choi. (2021) Effect of omalizumab as add-on therapy to Quality of Life Questionnaire for Korean Asthmatics (KAQLQ) in Korean patients with severe persistent allergic asthma. The Korean Journal of Internal Medicine 36:4, pages 1001-1013.
Crossref
Crossref
Stephan Vlaminck, Frederic Acke, Emmanuel Prokopakis, Kato Speleman, Hideyuki Kawauchi, Jean-Christophe van Cutsem, Peter W. Hellings, Mark Jorissen, Sven Seys, Claus Bachert, Thibaut Van Zele, Bart N. Lambrecht & Philippe Gevaert. (2020) Surgery in Nasal Polyp Patients: Outcome After a Minimum Observation of 10 Years. American Journal of Rhinology & Allergy 35:4, pages 449-457.
Crossref
Crossref
Bing Liu, Junxia Wang & Zhijuan Ren. (2021) SKP2-Promoted Ubiquitination of FOXO3 Promotes the Development of Asthma. The Journal of Immunology 206:10, pages 2366-2375.
Crossref
Crossref
Anna M. Hedman, Ralf Kuja‐Halkola, Anne K. Örtqvist, Marianne Hage, Catarina Almqvist & Björn Nordlund. (2021) Genetic effects of allergen‐specific IgE levels on exhaled nitric oxide in schoolchildren with asthma: The STOPPA twin study. Pediatric Allergy and Immunology 32:4, pages 709-719.
Crossref
Crossref
Meng Chen, Kirk ShepardIIII, Ming Yang, Pranil Raut, Hooman Pazwash, Cecile T.J. Holweg & Eugene Choo. (2021) Overlap of allergic, eosinophilic and type 2 inflammatory subtypes in moderate‐to‐severe asthma. Clinical & Experimental Allergy 51:4, pages 546-555.
Crossref
Crossref
Angelica Tiotiu. (2021) Applying personalized medicine to adult severe asthma. Allergy and Asthma Proceedings 42:1, pages e8-e16.
Crossref
Crossref
Joytri Dutta, Sabita Singh, Archita Ray & Ulaganathan Mabalirajan. 2021. Targeting Cellular Signalling Pathways in Lung Diseases. Targeting Cellular Signalling Pathways in Lung Diseases
97
125
.
Archita Ray, Sabita Singh, Joytri Dutta & Ulaganathan Mabalirajan. 2021. Targeting Cellular Signalling Pathways in Lung Diseases. Targeting Cellular Signalling Pathways in Lung Diseases
27
51
.
Vuyelwa Ndlovu, Moses John Chimbari & Elopy Sibanda. (2020) Assessing the nature of asthma in African epidemiological studies: a scoping review protocol. Systematic Reviews 9:1.
Crossref
Crossref
Hyun Jung Jin. (2020) Biological treatments for severe asthma. Yeungnam University Journal of Medicine 37:4, pages 262-268.
Crossref
Crossref
Katherina B. Sreter, Sanja Popovic-Grle, Marina Lampalo, Marcela Konjevod, Lucija Tudor, Matea Nikolac Perkovic, Irena Jukic, Jasna Bingulac-Popovic, Hana Safic Stanic, Jasenka Markeljevic, Nela Pivac & Dubravka Svob Strac. (2020) Plasma Brain-Derived Neurotrophic Factor (BDNF) Concentration and BDNF/TrkB Gene Polymorphisms in Croatian Adults with Asthma. Journal of Personalized Medicine 10:4, pages 189.
Crossref
Crossref
Désirée Larenas-Linnemann, Laura Gochicoa-Rangel, Alejandra Macías-Weinmann, Mario Soto-Ramos, Jorge A. Luna-Pech, Abelardo Elizondo-Ríos, Blanca E. Del Río-Navarro, Dante Daniel Hernández-Colín, Salvador García-Maldonado, Benjamín Zepeda, Eric A. Martínez-Infante & Juan Carlos Vázquez. (2020) Consenso mexicano en relación con la fracción exhalada de óxido nítrico (FeNO) en asma 2020. Revista Alergia México 67, pages s1-s25.
Crossref
Crossref
Daniel Hamilton & Heather Lehman. (2019) Asthma Phenotypes as a Guide for Current and Future Biologic Therapies. Clinical Reviews in Allergy & Immunology 59:2, pages 160-174.
Crossref
Crossref
Renaud Louis, Fabrice Bureau & Christophe J. Desmet. (2020) Advances toward precision medicine for asthma. Biochemical Pharmacology 179, pages 114081.
Crossref
Crossref
Erika von Mutius & Hermelijn H Smits. (2020) Primary prevention of asthma: from risk and protective factors to targeted strategies for prevention. The Lancet 396:10254, pages 854-866.
Crossref
Crossref
John W. Upham & Lisa M. Jurak. (2020) How do biologicals and other novel therapies effect clinically used biomarkers in severe asthma?. Clinical & Experimental Allergy.
Crossref
Crossref
Kjell Larsson, Hannu Kankaanranta, Christer Janson, Lauri Lehtimäki, Björn Ställberg, Anders Løkke, Kristian Høines, Klaus Roslind & Charlotte Suppli Ulrik. (2020) Bringing asthma care into the twenty-first century. npj Primary Care Respiratory Medicine 30:1.
Crossref
Crossref
Degan Lu, Jiameng Lu, Xiaoqing Ji, Yanbo Ji, Zewen Zhang, Haiying Peng, Fei Sun & Caiqing Zhang. (2020) IL‑27 suppresses airway inflammation, hyperresponsiveness and remodeling via the STAT1 and STAT3 pathways in mice with allergic asthma. International Journal of Molecular Medicine 46:2, pages 641-652.
Crossref
Crossref
R Palova, J Adamcakova, D Mokra & J Mokry. (2020) Bronchial Asthma: Current Trends in Treatment. Acta Medica Martiniana 20:1, pages 9-17.
Crossref
Crossref
Hendrik Beckert, Helen Meyer-Martin, Roland Buhl, Christian Taube & Sebastian Reuter. (2020) Single and Synergistic Effects of Type 2 Cytokines on Eosinophils and Asthma Hallmarks. The Journal of Immunology 204:3, pages 550-558.
Crossref
Crossref
Mahmoud I. Abdel-Aziz, Anne H. Neerincx, Susanne J. Vijverberg, Aletta D. Kraneveld & Anke H. Maitland-van der Zee. (2020) Omics for the future in asthma. Seminars in Immunopathology 42:1, pages 111-126.
Crossref
Crossref
Jakub Novosad & Irena Krčmová. (2020) Evolution of our view on the IgE molecule role in bronchial asthma and the clinical effect of its modulation by omalizumab: Where do we stand today?. International Journal of Immunopathology and Pharmacology 34, pages 205873842094238.
Crossref
Crossref
Hiroyuki Nagase, Mitsuru Adachi, Kazuto Matsunaga, Atsushi Yoshida, Tomoko Okoba, Nobuya Hayashi, Kahaku Emoto & Yuji Tohda. (2020) Prevalence, disease burden, and treatment reality of patients with severe, uncontrolled asthma in Japan. Allergology International 69:1, pages 53-60.
Crossref
Crossref
Mattis Gottlow, David J. Svensson, Ilya Lipkovich, Monika Huhn, Karin Bowen, Peter Wessman & Gene Colice. (2019) Application of structured statistical analyses to identify a biomarker predictive of enhanced tralokinumab efficacy in phase III clinical trials for severe, uncontrolled asthma. BMC Pulmonary Medicine 19:1.
Crossref
Crossref
Yusuke Yamazumi, Oh Sasaki, Saki Suyama-Fuchino, Kazuyoshi Kohu, Yuki Kamoshida, Hiroaki Harada, Keishi Fujio, Takeaki Oda & Tetsu Akiyama. (2019) The RNA-binding protein Mex-3B plays critical roles in the development of steroid-resistant neutrophilic airway inflammation. Biochemical and Biophysical Research Communications 519:2, pages 220-226.
Crossref
Crossref
Tomoko Nishio, Keiko Wakahara, Yoshihiro Suzuki, Naoki Nishio, Suguru Majima, Saya Nakamura, Masaaki Teranishi, Masahiro Nakatochi, Michihiko Sone & Yoshinori Hasegawa. (2019) Mixed cell type in airway inflammation is the dominant phenotype in asthma patients with severe chronic rhinosinusitis. Allergology International 68:4, pages 515-520.
Crossref
Crossref
Timothy N. Perkins, Elizabeth A. Oczypok, Regina E. Dutz, Mason L. Donnell, Michael M. Myerburg & Tim D. Oury. (2019) The receptor for advanced glycation end products is a critical mediator of type 2 cytokine signaling in the lungs. Journal of Allergy and Clinical Immunology 144:3, pages 796-808.e12.
Crossref
Crossref
Katrien AB Eger & Elisabeth H Bel. (2019) The emergence of new biologics for severe asthma. Current Opinion in Pharmacology 46, pages 108-115.
Crossref
Crossref
Jung-Eun Kim, Keunok Jung, Jeong-Ah Kim, Seung-Hyun Kim, Hae-Sim Park & Yong-Sung Kim. (2019) Engineering of anti-human interleukin-4 receptor alpha antibodies with potent antagonistic activity. Scientific Reports 9:1.
Crossref
Crossref
Alberta G. A. Paul, Lyndsey M. Muehling, Jacob D. Eccles & Judith A. Woodfolk. (2019) T cells in severe childhood asthma. Clinical & Experimental Allergy 49:5, pages 564-581.
Crossref
Crossref
Mary Clare McGregor, James G. Krings, Parameswaran Nair & Mario Castro. (2019) Role of Biologics in Asthma. American Journal of Respiratory and Critical Care Medicine 199:4, pages 433-445.
Crossref
Crossref
Laurent Peyrin-Biroulet, Stephen Demarest & Ajay Nirula. (2019) Bispecific antibodies: The next generation of targeted inflammatory bowel disease therapies. Autoimmunity Reviews 18:2, pages 123-128.
Crossref
Crossref
Marie Godar, Kim Deswarte, Karl Vergote, Michael Saunders, Hans de Haard, Hamida Hammad, Christophe Blanchetot & Bart N. Lambrecht. (2018) A bispecific antibody strategy to target multiple type 2 cytokines in asthma. Journal of Allergy and Clinical Immunology 142:4, pages 1185-1193.e4.
Crossref
Crossref
Wenchao Tang, Yi Shang, Bin Xiao, Peitong Wen, Ruoyun Lyu & Ke Ning. (2018) The Cell Research Trends of Asthma: A Stem Frequency Analysis of the Literature. Journal of Healthcare Engineering 2018, pages 1-10.
Crossref
Crossref
Ajay P. Nayak, Deepak A. Deshpande & Raymond B. Penn. (2018) New targets for resolution of airway remodeling in obstructive lung diseases. F1000Research 7, pages 680.
Crossref
Crossref